Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of botulinum toxin A on quality of life in women with overactive bladder and urge urinary incontinence
IRCT20100301003461N10Phase 2Completed
- Sponsor
- Kermanshah University of Medical Sciences
- Start
- Jul 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, single-arm trial of botulinum toxin type A in overactive bladder (OAB) and urge incontinence, sponsored by Kermanshah University of Medical Sciences. Primary endpoint: Quality of life improvement. Started Jul 2017; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
overactive bladder (OAB)urge incontinence
Beyond the preview
Go deeper on IRCT20100301003461N10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20100301003461N10.